Canadian investment bank AltaCorp Capital has published a research report explaining options for producing cannabinoids from sources beyond cannabis. Analyst and Managing Director David Kideckel, PhD,  explained in “Synthetically-Derived...

This article was published originally at 420 Investor in October A highly disruptive technology that I have discussed over the past few years appears to be gaining traction. Biosynthesis,...